ADCT — ADC THERAPEUTICS SA

Ownership history in STEMPOINT CAPITAL LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in ADC THERAPEUTICS SA (ADCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.3% (2025 Q4)
Avg. % of fund
0.26%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 502,570 +219,284 +77.4% 0.30% $1.8M $3.53
2025 Q3 UNCHANGED 283,286 — 0% 0.23% $1.1M $4.00
2025 Q2 INITIATED 283,286 — — 0.24% $759K $2.68
% of Fund (quarterly)    ADCT price (monthly, adj. close)

Other funds also holding ADCT

As of 2025 Q4 — sorted by position size

Vantage Consulting Group Inc 3Y 12.23% Prosight Management, LP 3Y 7Y 6.18% Redmile Group, LLC 3Y 7Y 4.07% TCG Crossover Management, LLC 3Y 1.33% PLATINUM INVESTMENT MANAGEMENT LTD 3Y 7Y 0.81% Nantahala Capital Management, LLC 3Y 7Y 0.64% ORBIMED ADVISORS LLC 3Y 7Y 0.42% Blue Owl Capital Holdings LP 3Y 0.22% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 0.19% DAFNA Capital Management LLC 3Y 7Y 0.06%
← Back to STEMPOINT CAPITAL LP Holdings